Global Patent Index - EP 1671129 A1

EP 1671129 A1 20060621 - COMPOUNDS AND METHODS FOR PROMOTING ANGIOGENESIS BY USING A GAMMA-SECRETASE INHIBITOR OR INHIBITING THE GAMMA-SECRETASE PATHWAY

Title (en)

COMPOUNDS AND METHODS FOR PROMOTING ANGIOGENESIS BY USING A GAMMA-SECRETASE INHIBITOR OR INHIBITING THE GAMMA-SECRETASE PATHWAY

Title (de)

VERBINDUNGEN UND VERFAHREN ZUR FÖRDERUNG DER ANGIOGENESE DURCH VERWENDUNG EINES GAMMA-SECRETASE-INHIBITORS ODER HEMMEN DES GAMMA-SECRETASE-WEGS

Title (fr)

COMPOSES ET METHODES POUR FAVORISER L'ANGIOGENESE, AU MOYEN D'UN INHIBITEUR DE LA GAMMA SECRETASE ET EN INHIBANT LA VOIE DE LA GAMMA SECRETASE

Publication

EP 1671129 A1 20060621 (EN)

Application

EP 04749182 A 20040721

Priority

  • SE 2004001146 W 20040721
  • US 48834503 P 20030721
  • SE 0302111 A 20030721

Abstract (en)

[origin: WO2005008250A1] Angiogenesis may be initiated or increased through the use of gamma-secretase inhibitors. The gamma-secretase inhibitor DAPT can initiate and increase angiogenesis. Methods for initiating and increasing angiogenesis are used for disease prevention and treatment as well as for generating research models.

IPC 1-7

G01N 33/68; A61K 38/00; A61K 39/00; A61P 9/00

IPC 8 full level

A61K 31/00 (2006.01); A61P 9/00 (2006.01); C12Q 1/37 (2006.01); G01N 33/68 (2006.01)

CPC (source: EP)

A61K 31/00 (2013.01); A61P 9/00 (2017.12); C12Q 1/37 (2013.01); G01N 33/6893 (2013.01)

Citation (search report)

See references of WO 2005008250A1

Citation (examination)

WO 2004073630 A2 20040902 - ROSKAMP RES LLC [US], et al

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2005008250 A1 20050127; EP 1671129 A1 20060621

DOCDB simple family (application)

SE 2004001146 W 20040721; EP 04749182 A 20040721